Fechner R E
Hum Pathol. 1977 May;8(3):255-68. doi: 10.1016/s0046-8177(77)80022-1.
A consecutive series of 12 benign hepatic lesions in women consisted of six cases of focal nodular hyperplasia and six cases of liver cell adenoma. Five of the six women with liver cell adenoma and two of the six with focal nodular hyperplasia had taken orally active contraceptive hormones. These few cases reflect a similar impression gained from a critical analysis of the literature, namely, that focal nodular hyperplasia may be unrelated to the oral administration of contraceptive hormones, whereas the increase in liver cell adenoma reported in recent years is probably related to such therapy. Two women with liver cell adenomas were asymptomatic six and four years after incomplete resection of the tumor. These are the longest intervals thus far reported for uncomplicated survival in incompletely resected liver cell adenoma.
一组连续的12例女性肝脏良性病变,其中包括6例局灶性结节性增生和6例肝细胞腺瘤。6例肝细胞腺瘤患者中有5例,6例局灶性结节性增生患者中有2例曾口服活性避孕激素。这几例病例反映了对文献进行批判性分析后得出的类似印象,即局灶性结节性增生可能与口服避孕激素无关,而近年来报道的肝细胞腺瘤增多可能与这种治疗有关。两名肝细胞腺瘤女性患者在肿瘤不完全切除后分别6年和4年无症状。这是迄今为止报道的不完全切除肝细胞腺瘤后无并发症存活的最长间隔时间。